B BMY

Bristol-Myers Squibb Company

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Bristol-Myers Squibb Company (BMY) is a leading biopharmaceutical firm based in New York City, recognized for its pioneering advancements in oncology, immunology, cardiovascular diseases, and hematology. With a robust portfolio of established therapies and a strong pipeline focused on addressing sig...

$62.47

+1.76% (+$1.08)

Volume 12.67M

52W High $68.64

52W Low $43.20

Market Cap $123.53B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Oct 29, 2026 Beat

Actual: $1.35 vs. Consensus: $1.21

Price Chart

EPS History: Consensus vs Actual

Last 11 quarters

Price Movement Around Earnings

Q3 2026 Oct 29, 2026

1-Day: +1.76%

Q2 2026 Jul 30, 2026

1-Day: +0.69%

5-Day: +1.59%

Q1 2026 Apr 30, 2026

1-Day: -3.91%

5-Day: -6.01%

Q1 2026 Apr 23, 2026

1-Day: -0.53%

5-Day: -1.29%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'26	$13.07B	+6.9%	68.3%	21.8%	$2.16B
Q2'26	$12.97B	+5.7%	71.3%	31.0%	$3.32B
Q1'26	$11.49B	+2.6%	70.2%	29.3%	$2.68B
Q4'25	$12.50B	+1.3%	67.2%	22.5%	$1.09B
Q3'25	$12.22B	+2.8%	71.9%	29.8%	$2.20B
Q2'25	$12.27B	+0.6%	72.5%	30.8%	$1.31B
Q1'25	$11.20B	-5.6%	72.9%	31.2%	$2.46B
Q4'24	$12.34B	+7.5%	61.0%	4.1%	$72.0M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Oct 29, 2026	$1.21	$1.31	$1.35	+11.57%	Beat
Q2 2026	Jul 30, 2026	$1.59	$1.72	$2.04	+28.30%	Beat
Q1 2026	Apr 30, 2026	$1.42	$1.46	$1.58	+11.27%	Beat
Q1 2026	Apr 23, 2026	$1.46	$1.51	--	--	--
Q4 2025	Feb 5, 2026	$1.20	$1.55	$1.26	+5.00%	Missed
Q3 2025	Oct 30, 2025	$1.52	$1.88	$1.63	+7.24%	Missed
Q2 2025	Jul 31, 2025	$1.10	$1.21	$1.46	+32.73%	Beat
Q1 2025	Apr 24, 2025	$1.50	$1.62	$1.80	+20.00%	Beat
Q4 2024	Feb 6, 2025	$1.47	$1.57	$1.67	+13.61%	Beat
Q3 2024	Oct 31, 2024	$1.50	$1.59	$1.80	+20.00%	Beat
Q2 2024	Jul 26, 2024	$1.63	$1.66	$2.07	+26.99%	Beat
Q1 2024	Apr 25, 2024	-$4.14	-$4.14	-$4.40	-6.28%	Missed